Novartis eye care division Alcon has secured European approval for AcrySof IQ Aspheric IOL with the UltraSert Pre-loaded Delivery System, which is used treat patients undergoing cataract surgery.
The pre-loaded intraocular lens delivery system has been approved for the European CE Mark, the firm said.
This system integrates control of a manually loaded device with safety and convenience offered by a disposable, pre-loaded injector. The combination has been found to improve implantation of the AcrySof IQ Aspheric IOL.
Alcon Research & Development surgical head Franck Leveiller said: "Alcon is committed to advancing cataract surgery through the continuous development of new technologies and processes.
"Every detail of the UltraSert Pre-loaded Delivery System has been engineered with the needs of surgeons, technicians and the outcomes for their patients in mind.
"By simplifying the device preparation and maximizing surgeon control in a single-use system, we have cleared the path for more streamlined procedures and potentially improved patient outcomes."
The device is equipped with TensionGlideTM Plunger which is a spring-controlled mechanism facilitating smooth and controlled delivery of the AcrySof IQ IOL into the capsular bag of the eye during a cataract procedure. It also features a plunger tip which supports consistent IOL folding and precise placement of the IOL into the capsular bag.
The system thus offers the plus of less invasive corneal incision during cataract surgery and can eliminate the need for deeper incisions.
Recently, Alcon has also received the CE Mark for its trifocal presbyopia-correcting AcrySof IOL.
Image: Novartis headquarters in Basel, Switzerland. Photo: courtesy of Andrew / Wikipedia.